Area of research
Genetics · Epidemiology
Research interest
Research interests include Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Brain Metastases and Treatment, and Cancer, Hypoxia, and Metabolism.
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Chromosome 1p Loss and 1q Gain for Grading of Meningioma
White matter connections within the central sulcus subserving the somato-cognitive action network
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip
The evolving landscape of brain metastasis: volume II
Single-cell atlas of the human brain vasculature across development, adulthood and disease
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome
Development and validation of a molecular classifier of meningiomas
A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology
Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Shaping the brain vasculature in development and disease in the single-cell era
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Radiographic Predictors of Occult Intracranial Involvement in Olfactory Neuroblastoma Patients
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i> -mutant glioma formation
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
A clinically applicable integrative molecular classification of meningiomas
A molecularly integrated grade for meningioma
The transcriptional landscape of Shh medulloblastoma
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma